These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38174394)

  • 1. [Neural networks in addiction].
    Goudriaan AE; Crunelle CL; Wolf C; Schellekens A
    Tijdschr Psychiatr; 2023; 65(10):609-612. PubMed ID: 38174394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural Underpinnings of Social Stress in Substance Use Disorders.
    Sahani V; Hurd YL; Bachi K
    Curr Top Behav Neurosci; 2022; 54():483-515. PubMed ID: 34971448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use Disorders.
    Icick R; Moggi F; Slobodin O; Dom G; Mathys F; van den Brink W; Levin FR; Blankers M; Kaye S; Demetrovics Z; van de Glind G; Velez-Pastrana MC; Schellekens ASA;
    Eur Addict Res; 2020; 26(4-5):201-210. PubMed ID: 32570249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptom networks in patients with substance use disorders.
    Rutten RJT; Broekman TG; Schippers GM; Schellekens AFA
    Drug Alcohol Depend; 2021 Dec; 229(Pt B):109080. PubMed ID: 34634562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The associations of comorbid substance use disorders and psychiatric conditions with adolescent brain structure and function: A review.
    Kroll DS; Feldman DE; Wang SA; Zhang R; Manza P; Wiers CE; Volkow ND; Wang GJ
    J Neurol Sci; 2020 Nov; 418():117099. PubMed ID: 32866814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive-behavioral therapies for depression and substance use disorders: An overview of traditional, third-wave, and transdiagnostic approaches.
    Vujanovic AA; Meyer TD; Heads AM; Stotts AL; Villarreal YR; Schmitz JM
    Am J Drug Alcohol Abuse; 2017 Jul; 43(4):402-415. PubMed ID: 27494547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A High-Sugar Diet Consumption, Metabolism and Health Impacts with a Focus on the Development of Substance Use Disorder: A Narrative Review.
    Witek K; Wydra K; Filip M
    Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comorbidity of posttraumatic stress disorder and addiction from a biopsychosocial perspective].
    Kapfhammer HP
    Neuropsychiatr; 2022 Mar; 36(1):1-18. PubMed ID: 33439473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proactive psychiatry in addiction].
    Hendriks VM; Dom G
    Tijdschr Psychiatr; 2021; 63(2):125-128. PubMed ID: 33620724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood maltreatment, altered limbic neurobiology, and substance use relapse severity via trauma-specific reductions in limbic gray matter volume.
    Van Dam NT; Rando K; Potenza MN; Tuit K; Sinha R
    JAMA Psychiatry; 2014 Aug; 71(8):917-25. PubMed ID: 24920451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance use disorders in patients with intellectual disability admitted to psychiatric hospitalisation.
    Salavert J; Clarabuch A; Fernández-Gómez MJ; Barrau V; Giráldez MP; Borràs J
    J Intellect Disabil Res; 2018 Nov; 62(11):923-930. PubMed ID: 29961996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzodiazepine prescription practices and substance abuse in persons with severe mental illness.
    Clark RE; Xie H; Brunette MF
    J Clin Psychiatry; 2004 Feb; 65(2):151-5. PubMed ID: 15003066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do trauma history and PTSD symptoms influence addiction relapse context?
    Norman SB; Tate SR; Anderson KG; Brown SA
    Drug Alcohol Depend; 2007 Sep; 90(1):89-96. PubMed ID: 17459611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance use problems and associated psychiatric symptoms among adolescents in primary care.
    Shrier LA; Harris SK; Kurland M; Knight JR
    Pediatrics; 2003 Jun; 111(6 Pt 1):e699-705. PubMed ID: 12777588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
    Mazza M; Mandelli L; Di Nicola M; Harnic D; Catalano V; Tedeschi D; Martinotti G; Colombo R; Bria P; Serretti A; Janiri L
    J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impulsivity traits and neurocognitive mechanisms conferring vulnerability to substance use disorders.
    Verdejo-Garcia A; Albein-Urios N
    Neuropharmacology; 2021 Feb; 183():108402. PubMed ID: 33189766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Substance use disorders and ADHD: an overview of recent Dutch research].
    van Emmerik-van Oortmerssen K; Crunelle CL; Carpentier PJ
    Tijdschr Psychiatr; 2013; 55(11):861-6. PubMed ID: 24242145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered resting functional connectivity patterns associated with problematic substance use and substance use disorders during adolescence.
    Rakesh D; Lv J; Zalesky A; Allen NB; Lubman DI; Yücel M; Whittle S
    J Affect Disord; 2021 Jan; 279():599-608. PubMed ID: 33190110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addiction resistance: Definition, validation and association with mastery.
    Kendler KS; Myers J
    Drug Alcohol Depend; 2015 Sep; 154():236-42. PubMed ID: 26187457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The centrality of craving in network analysis of five substance use disorders.
    Gauld C; Baillet E; Micoulaud-Franchi JA; Kervran C; Serre F; Auriacombe M
    Drug Alcohol Depend; 2023 Apr; 245():109828. PubMed ID: 36868091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.